Generation and Characterization of a Human Nanobody Against VEGFR-2

Acta Pharmacologica Sinica - United Kingdom
doi 10.1038/aps.2016.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, Against VEGFR-1 and Members of the Structurally Related PDGFR Family

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Generation and Characterization of Monoclonal Antibodies Against the N-Terminus of Alpha-2-Antiplasmin

PLoS ONE
Multidisciplinary
2018English

Attenuation of VEGFR-2 Expression by sFlt-1 and Low Oxygen in Human Placenta

PLoS ONE
Multidisciplinary
2013English

Analysis of Biological Effects and Signaling Properties of FLT-1 (VEGFR-1) and KDR (VEGFR-2)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Combined Blockade of VEGFR-2 and VEGFR-3 Inhibits Inflammatory Lymphangiogenesis in Early and Middle Stages

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Rapamycin Suppresses Angiogenesis and Lymphangiogenesis in Melanoma by Downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 Expression

OncoTargets and Therapy
OncologyPharmacology
2019English

Generation and Characterization of Human Insulin-Releasing Cell Lines

BMC Cell Biology
Cell Biology
2009English

In Situ Validation of VEGFR-2 and Α v SS 3 Integrin as Targets for Breast Lesion Characterization

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy